[go: up one dir, main page]

NO853012L - Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem. - Google Patents

Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.

Info

Publication number
NO853012L
NO853012L NO85853012A NO853012A NO853012L NO 853012 L NO853012 L NO 853012L NO 85853012 A NO85853012 A NO 85853012A NO 853012 A NO853012 A NO 853012A NO 853012 L NO853012 L NO 853012L
Authority
NO
Norway
Prior art keywords
type
interfenon
peptides
expression
genetic sequences
Prior art date
Application number
NO85853012A
Other languages
English (en)
Other versions
NO177863C (no
NO177863B (no
Inventor
Rudolf Hauptmann
Peter Meindl
Guenther Adolf
Peter Swetly
Christian Pieler
Eva Rastl-Dworkin
Norbert Hauel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3428370A external-priority patent/DE3428370A1/de
Priority claimed from DE19853505060 external-priority patent/DE3505060A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO853012L publication Critical patent/NO853012L/no
Publication of NO177863B publication Critical patent/NO177863B/no
Publication of NO177863C publication Critical patent/NO177863C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO853012A 1984-08-01 1985-07-30 Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer NO177863C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3428370A DE3428370A1 (de) 1984-08-01 1984-08-01 Interferon, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen
DE19853505060 DE3505060A1 (de) 1985-02-14 1985-02-14 Neue interferone vom typ i, genetische sequenzen, die hierfuer codieren, und diese produzierende organismen

Publications (3)

Publication Number Publication Date
NO853012L true NO853012L (no) 1986-02-03
NO177863B NO177863B (no) 1995-08-28
NO177863C NO177863C (no) 1995-12-06

Family

ID=25823496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853012A NO177863C (no) 1984-08-01 1985-07-30 Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer

Country Status (21)

Country Link
EP (1) EP0170204B1 (no)
JP (2) JP2566909B2 (no)
KR (1) KR0136799B1 (no)
AT (1) ATE67786T1 (no)
AU (1) AU600653B2 (no)
BG (1) BG60445B2 (no)
CA (1) CA1340184C (no)
DD (1) DD246318A5 (no)
DE (1) DE3584198D1 (no)
DK (1) DK175194B1 (no)
ES (2) ES8609475A1 (no)
FI (1) FI90667C (no)
GR (1) GR851866B (no)
HK (1) HK187896A (no)
HU (1) HU205779B (no)
IE (1) IE58942B1 (no)
IL (1) IL75963A (no)
MX (1) MX9203645A (no)
NO (1) NO177863C (no)
NZ (1) NZ212937A (no)
PT (1) PT80901B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
DE3635867A1 (de) * 1986-10-22 1988-05-11 Boehringer Ingelheim Int Neue hefeexpressionsvektoren fuer ifn-omega, verfahren zu ihrer herstellung und deren verwendung
WO1999026663A2 (en) * 1997-11-20 1999-06-03 Vical, Inc. Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
WO2000040273A2 (en) * 1999-01-08 2000-07-13 Vical Incorporated Treatment of viral diseases using an interferon omega expressing polynucleotide
AU2003205502C1 (en) 2002-03-07 2011-08-25 Eidgenossische Technische Hochschule Zurich System and method for the production of recombinant glycosylated proteins in a prokaryotic host
KR100938026B1 (ko) * 2002-03-07 2010-01-21 아이드게노쉬쉐 테흐니쉐 호흐슐레 쥬리히 원핵 숙주에서 재조합 글리코실화 단백질의 생산방법 및생산계
EP2055189A1 (en) 2003-04-09 2009-05-06 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2004096852A1 (fr) * 2003-04-25 2004-11-11 The Institute Of Microbiology And Epidemiology, Academy Of Military Medical Sciemces, Pla Interferon$g(v) humain recombinant, son procede d'expression et ses utilisations
ES2703061T3 (es) 2005-05-11 2019-03-06 Eth Zuerich Proteínas N-glicosiladas recombinantes procedentes de células procariotas
EP3427749A1 (en) 2008-02-20 2019-01-16 GlaxoSmithKline Biologicals SA Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
TR201803015T4 (tr) 2009-11-19 2018-03-21 Glaxosmithkline Biologicals Sa Prokaryotik hücrelerde immünojenik polisakaridler üreten biyosentetik sistem.
CN103079591B (zh) 2010-05-06 2017-07-28 格林考瓦因有限公司 荚膜革兰氏阳性细菌生物缀合物疫苗
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1946283A (en) * 1982-08-18 1984-03-07 Cetus Corporation Interferon-alpha 6l
CA1217440A (en) * 1982-08-18 1987-02-03 Michael A. Innis INTERFERON .alpha. 6L
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
ATE47864T1 (de) * 1984-08-27 1989-11-15 Genentech Inc Verschiedenartige familie von menschlichen leukozyten-interferonen, zusammensetzungen, die diese enthalten, verfahren zu ihrer herstellung, sowie dna und transfektierte wirte hierfuer.

Also Published As

Publication number Publication date
IL75963A0 (en) 1985-12-31
HUT39477A (en) 1986-09-29
JP2567195B2 (ja) 1996-12-25
EP0170204A2 (de) 1986-02-05
ATE67786T1 (de) 1991-10-15
IE851906L (en) 1986-02-01
DD246318A5 (de) 1987-06-03
ES8708013A1 (es) 1987-09-01
JP2566909B2 (ja) 1996-12-25
FI852956A0 (fi) 1985-07-31
PT80901B (pt) 1989-01-17
NO177863C (no) 1995-12-06
BG60445B2 (bg) 1995-03-31
JPS61181381A (ja) 1986-08-14
EP0170204A3 (en) 1988-02-17
JPH06181771A (ja) 1994-07-05
KR870001310A (ko) 1987-03-13
ES545725A0 (es) 1986-08-01
DE3584198D1 (de) 1991-10-31
DK175194B1 (da) 2004-07-05
FI852956L (fi) 1986-02-02
IL75963A (en) 1992-05-25
AU600653B2 (en) 1990-08-23
AU4554985A (en) 1986-02-06
DK346385D0 (da) 1985-07-30
HU205779B (en) 1992-06-29
ES8609475A1 (es) 1986-08-01
DK346385A (da) 1986-02-02
NO177863B (no) 1995-08-28
HK187896A (en) 1996-10-18
CA1340184C (en) 1998-12-15
EP0170204B1 (de) 1991-09-25
PT80901A (de) 1985-09-01
GR851866B (no) 1985-12-02
FI90667B (fi) 1993-11-30
MX9203645A (es) 1992-09-01
ES552431A0 (es) 1987-09-01
KR0136799B1 (ko) 1998-04-25
FI90667C (fi) 1994-03-10
NZ212937A (en) 1991-08-27
IE58942B1 (en) 1993-12-01

Similar Documents

Publication Publication Date Title
NO853012L (no) Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.
UA32548C2 (uk) Ізольована послідовність днк, що кодує epsps фермент, ізольована послідовність днк, що кодує білок, який виявляє epsps активність, рекомбінантна двониткова молекула днк, спосіб одержання генетично трансформованих рослин
NO882946D0 (no) Konstruksjon av syntetisk dna og anvendelse derav i syntese av store polypeptider.
DE69503038D1 (de) Zellzyklusprotein in Säugetieren
ATE424410T1 (de) Interleukin-19.
ATE112574T1 (de) Igg-bindendes protein h, kodierendes gen dafür und verfahren zu seiner herstellung.
JPS615392B2 (no)
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
NZ224243A (en) Single chain urokinase type plasminogen activator with yeast type glycosylation and site directed mutants thereof
ATE73847T1 (de) Dna-fragment mit dem cyclodextrin-glycosyltransferase-strukturgen, expressionsvektor, mikroorganismen zur expression und herstellungsverfahren.
ATE386114T1 (de) Gene, die für lymphocyte spezifischen interferon- regulationsfaktor (lsirf) polypeptide kodiert
SG134394G (en) Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same

Legal Events

Date Code Title Description
MK1K Patent expired